Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication

Journal of Pharmacological Sciences

Volumn 127, Issue 1, 2015, Pages 6-9

  Hashimoto, Kenji ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Cognition; Delirium; Neuroplasticity; Neuroprotection; Sigma 1 receptor chaperone

Indexed keywords

CITALOPRAM; DONEPEZIL; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE GROWTH FACTOR; NEUROSTEROID; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SIGMA 1 OPIATE RECEPTOR; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; INDAN DERIVATIVE; PIPERIDINE DERIVATIVE; SIGMA OPIATE RECEPTOR; SIGMA-1 RECEPTOR;

CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DELIRIUM; DEPRESSION; DRUG EFFICACY; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG TOLERABILITY; EXECUTIVE FUNCTION; HUMAN; MENTAL DISEASE; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROPSYCHIATRIC DISEASE; NONHUMAN; POST STROKE DEPRESSION; POSTTRAUMATIC STRESS DISORDER; PROTEIN FUNCTION; PROTEIN MISFOLDING; PROTEIN STRUCTURE; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCHIZOPHRENIA; UNSPECIFIED SIDE EFFECT; AGONISTS; ANIMAL; BIOLOGICAL MODEL; MENTAL DISORDERS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; HUMANS; INDANS; MENTAL DISORDERS; MODELS, NEUROLOGICAL; NEUROTRANSMITTER AGENTS; PIPERIDINES; RECEPTORS, SIGMA; SEROTONIN UPTAKE INHIBITORS;

EID: 84921955984     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1016/j.jphs.2014.11.010     Document Type: Review

References (30)

1. T.P. Su, E.D. London, and J.H. Jaffe Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems Science 240 1988 219 221
2. 1-binding site Proc Natl Acad Sci U S A 93 1996 8072 8077
3. 2+ signaling and cell survival Cell 131 2007 596 610
4. T.P. Su, T. Hayashi, T. Maurice, S. Buch, and A.E. Ruoho The sigma-1 receptor chaperone as an inter-organelle signaling modulator Trends Pharmacol Sci 31 2010 557 566
5. T. Hayashi, S.Y. Tsai, T. Mori, M. Fujimoto, and T.P. Su Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders Expert Opin Ther Targets 15 2011 557 577
6. K. Hashimoto, and K. Ishiwata Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals Curr Pharm Des 12 2006 3857 3876
7. K. Hashimoto Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship Cent Nerv Syst Agents Med Chem 9 2009 197 204
8. T. Niitsu, M. Iyo, and K. Hashimoto Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases Curr Pharm Des 18 2012 875 883
9. K. Hashimoto Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression Prog Neurobiol 100 2013 15 29
10. N. Narita, K. Hashimoto, S. Tomitaka, and Y. Minabe Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain Eur J Pharmacol 307 1996 117 119
11. T. Ishima, Y. Fujita, and K. Hashimoto Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells Eur J Pharmacol 727 2014 167 173
12. 3 receptors and cellular signaling pathways PLoS One 3 2008 e2558
13. 11C]SA4503 Biol Psychiatry 62 2007 878 883
14. M.J. Millan, Y. Agid, M. Brüne, E.T. Bullmore, C.S. Carter, and N.S. Clayton Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy Nat Rev Drug Discov 11 2012 141 168
15. K. Hashimoto Targeting of NMDA receptors in the new treatment of schizophrenia Expert Opin Ther Targets 18 2014 1049 1063
16. M. Pabba, A.Y. Wong, N. Ahlskog, E. Hristova, D. Biscaro, and W. Nassrallah NMDA receptors are upregulated and trafficked to the plasma membrane after sigma-1 receptor activation in the rat hippocampus J Neurosci 34 2014 11325 11338
17. K. Hashimoto, Y. Fujita, and M. Iyo Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors Neuropsychopharmacology 32 2007 514 522
18. T. Ishima, Y. Fujita, M. Kohno, S. Kunitachi, M. Horio, and Y. Takatsu Improvement of phencyclidine-induced cognitive deficits in mice by subsequent subchronic administration of fluvoxamine, but not sertraline Open Clin Chem J 2 2009 7 11
19. T. Niitsu, M. Fujisaki, A. Shiina, T. Yoshida, T. Hasegawa, and N. Kanahara A randomized, double-blind, placebo-controlled trial of fluvoxamine in patients with schizophrenia: a preliminary study J Clin Psychopharmacol 32 2012 593 601
20. R. O'Sullivan, S.K. Inouye, and D. Meagher Delirium and depression: inter-relationship and clinical overlap in elderly people Lancet Psychiatry 1 2014 303 315
21. K. Hashimoto, and T. Furuse Sigma-1 receptor agonist fluvoxamine for delirium in older adults Int J Geriatr Psychiatry 27 2012 981 983
22. T. Omi, H. Tanimukai, D. Kanayama, Y. Sakagami, S. Tagami, and M. Okochi Fluvoxamine alleviates ER stress via induction of sigma-1 receptor Cell Death Dis 5 2014 e1332
23. S. Kunitachi, Y. Fujita, T. Ishima, M. Kohno, M. Horio, and Y. Tanibuchi Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors Brain Res 1279 2009 189 196
24. 3 receptors Prog Neuropsychopharmacol Biol Psychiatry 32 2008 1656 1659
25. 11C]SA4503 Int J Neuropsychopharmacol 12 2009 1127 1131
26. K. Hashimoto, and E.D. London Interactions of erythro-ifenprodil, threo-ifenprodil, erythro-idoifenprodil, and eloprodil with subtypes of sigma receptors Eur J Pharmacol 273 1995 307 310
27. 3 receptors PLoS One 7 2012 e37989
28. A. Kishimoto, M. Kaneko, Y. Gotoh, and K. Hashimoto Ifenprodil for the treatment of flashbacks in female posttraumatic stress disorder patients with a history of childhood sexual abuse Biol Psychiatry 71 2012 e7 8
29. T. Sasaki, K. Hashimoto, K. Okawada, J. Tone, A. Machizawa, and A. Tano Ifenprodil for the treatment of flashbacks in adolescent female posttraumatic stress disorder patients with a history of abuse Psychother Psychosom 82 2013 344 345
30. K. Hashimoto, T. Sasaki, and A. Kishimoto Old drug ifenprodil, new hope for PTSD with a history of childhood abuse Psychopharmacology (Berl) 227 2013 375 376